๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical Potential of Aldose Reductase Inhibitors in Diabetic Neuropathy

โœ Scribed by Dr Yoji Hamada, Jiro Nakamura

Book ID
120885999
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2004
Tongue
English
Weight
142 KB
Volume
3
Category
Article
ISSN
1177-4940

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Clinical and neurophysiological studies
Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy
โœ I. G. Lewin; I. A. D. O'Brien; M. H. Morgan; R. J. M. Corrall ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer ๐ŸŒ English โš– 436 KB

The effect of sorbinil (200 mg daily for 4 weeks) was examined in 13 patients, mean age 59.7 years (range 42-72 years), with symptomatic diabetic neuropathy of mean duration 6 year (range 1-18 years). In this double-blind, placebo-controlled crossover trial, studies were made of motor, sensory and a